drugset / Trial / NCT04144101

Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid Arthritis

NCT04144101

Phase 4 Completed 40 enrolled Chung Shan Medical University
RandomizedParallel-groupOpen-labelBasic science

Summary

Comparison of lower dosage etoricoxib (60 mg daily) with aceclofenac (100 mg bid) for their efficacy and safety in the treatment of rheumatoid arthritis (RA).

Timeline

Start
2007-03-01
Primary completion
2007-07-31
Completion
2007-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Aceclofenac Small molecule 100 mg Oral
Subject Etoricoxib Small molecule 60 mg Oral

Indications